Explore more publications!

Djibouti Health Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Djibouti Health Journal.

Press releases published on September 3, 2025

PharmaCorp to Acquire Two Pharmacies in Western Canada
Microbix Hosts Ontario Minister Stephen Crawford
Roivant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients
Immunovant Unveils Durability and Treatment-Free Six-month Remission Data with Potential to Change Treatment Paradigm for Uncontrolled Graves' Disease Patients
Society for Science Recognizes Top 300 Middle School Innovators in Nation’s Premier STEM Competition
Arcutis Submits Supplemental New Drug Application for ZORYVE® (roflumilast) Cream 0.3% to Expand Indication for Treatment of Plaque Psoriasis in Children Ages 2 to 5
Artelo Biosciences Affirms Strong Partnering Outlook for ART27.13 Following Positive Interim Phase 2 CAReS Results
Clinical Asset Management leader TRIMEDX adds to leadership team with key technology hire to accelerate innovation and AI strategy
KFSHRC Reinforces Global Leadership as Early Adopter of Advanced cell and Gene Therapies
2025 Rising Stars to Take the Stage at BioNTX iC³® Life Science & Healthcare Innovation Summit
Smith+Nephew extends Advanced Wound Bioactives portfolio with US launch of CENTRIO Platelet-Rich-Plasma System
TeamACO reduces avoidable costs by $15.8M for Medicare value-based care program
AMA Announces 2025 Joy in Medicine Recognized Health Organizations
Carbon Capture Made Scalable: Decarbontek Debuts Breakthrough Modular Adsorbent Technology
MATTER Launches Major Initiative to Improve Health System in Ukraine
BVI Unveils Virtuoso® – A Novel Dual-Function Surgical Platform for Cataract and Vitreoretinal Procedures
10 Surgeons Join USOSM Partner Practices in Eight States
Ernexa Therapeutics Announces Presentation At The H.C. Wainwright 27th Annual Global Investment Conference
PharmAla Incorporates Australian Entity for Clinical Research
Dogwood Therapeutics to Participate in Fireside Chat at the H.C. Wainwright 27th Annual Global Investment Conference

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions